APRT anticorps (C-Term)
Aperçu rapide pour APRT anticorps (C-Term) (ABIN389427)
Antigène
Voir toutes APRT AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 143-170, C-Term
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogène
- This APRT antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 143-170 amino acids from the C-terminal region of human APRT.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- WB: 1:1000. WB: 1:1000. IHC-P: 1:50~100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
Date de péremption
- 6 months
-
-
-
: "Adenine phosphoribosyltransferase (APRT) deficiency: identification of a novel nonsense mutation." dans: BMC nephrology, Vol. 15, pp. 102, (2014) (PubMed).
-
-
- APRT (Adenine Phosphoribosyltransferase (APRT))
-
Autre désignation
- APRT
-
Sujet
- A conserved feature of APRT is the distribution of CpG dinucleotides. This enzyme catalyzes the formation of AMP and inorganic pyrophosphate from adenine and 5-phosphoribosyl-1-pyrophosphate (PRPP). It also produces adenine as a by-product of the polyamine biosynthesis pathway. A homozygous deficiency in this enzyme causes 2,8-dihydroxyadenine urolithiasis.
-
Poids moléculaire
- 19608
-
ID gène
- 353
-
NCBI Accession
- NP_000476, NP_001025189
-
UniProt
- P07741
-
Pathways
- Ribonucleoside Biosynthetic Process
Antigène
-